High-Throughput Kinetic Analysis for Target-Directed Covalent Ligand Discovery

被引：48

作者：

Craven, Gregory B. ^{[1
,2
]}

Affron, Dominic P. ^{[1
]}

Allen, Charlotte E. ^{[1
]}

Matthies, Stefan ^{[1
]}

Greener, Joe G. ^{[2
]}

Morgan, Rhodri M. L. ^{[2
]}

Tate, Edward W. ^{[1
]}

Armstrong, Alan ^{[1
]}

Mann, David J. ^{[2
]}

机构：

[1] Imperial Coll London, Dept Chem, South Kensington Campus, London SW7 2AZ, England

[2] Imperial Coll London, Dept Life Sci, South Kensington Campus, London SW7 2AZ, England

来源：

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION | 2018年 / 57卷 / 19期

基金：

英国工程与自然科学研究理事会; 英国生物技术与生命科学研究理事会;

关键词：

Cdk2; covalent inhibition; fragment-based drug discovery; kinetics; protein modification; DRUG DISCOVERY; IRREVERSIBLE INHIBITORS; BINDING FRAGMENTS; PROTEIN-KINASES; CANCER-THERAPY; ASSAY; BIOLOGY; DESIGN; THIOLS; PROBES;

D O I：

10.1002/anie.201711825

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Cysteine-reactive small molecules are used as chemical probes of biological systems and as medicines. Identifying high-quality covalent ligands requires comprehensive kinetic analysis to distinguish selective binders from pan-reactive compounds. Quantitative irreversible tethering (qIT), a general method for screening cysteine-reactive small molecules based upon the maximization of kinetic selectivity, is described. This method was applied prospectively to discover covalent fragments that target the clinically important cell cycle regulator Cdk2. Crystal structures of the inhibitor complexes validate the approach and guide further optimization. The power of this technique is highlighted by the identification of a Cdk2-selective allosteric (type IV) kinase inhibitor whose novel mode-of-action could be exploited therapeutically.

引用

页码：5257 / 5261

页数：5

共 50 条

[1] The utility of yeast as a tool for cell- based, target-directed high-throughput screening
Norcliffe, J. L.
Alvarez-Ruiz, E.
Martin-Plaza, J. J.
Steel, P. G.
Denny, P. W.
PARASITOLOGY, 2014, 141 (01) : 8 - 16
[2] Discovery of PLD4 modulators by high-throughput screening and kinetic analysis
Lee, Jinny Claire
Shirey, Ryan J.
Turner, Lewis D.
Park, Hyeri
Lairson, Luke L.
Janda, Kim D.
RESULTS IN CHEMISTRY, 2024, 7
[3] High-throughput computational workflow for ligand discovery in catalysis with the CSD
Short, Marc A. S.
Tovee, Clare A.
Willans, Charlotte E.
Nguyen, Bao N.
CATALYSIS SCIENCE & TECHNOLOGY, 2023, 13 (08) : 2407 - 2420
[4] Quantitative Irreversible Tethering (qIT) for Target-directed Covalent Fragment Screening
Craven, Gregory B.
Armstrong, Alan
Mann, David J.
BIO-PROTOCOL, 2020, 10 (24):
[5] Towards high-throughput functional target discovery in angiogenesis research
van Beijnum, JR
Eijgelaar, WJ
Griffioen, AW
TRENDS IN MOLECULAR MEDICINE, 2006, 12 (01) : 44 - 52
[6] Yeast Genomics Technique for High-Throughput Drug Target Discovery
Sun, Zijun
Sun, Yanyan
Zhou, Yaxian
Wan, Yakun
DRUG DEVELOPMENT RESEARCH, 2012, 73 (07) : 398 - 405
[7] High-throughput analysis of behavior for drug discovery
Alexandrov, Vadim
Brunner, Dani
Hanania, Taleen
Leahy, Emer
EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 750 : 82 - 89
[8] High-throughput methods in aptamer discovery and analysis
Cole, Kyle H.
Luptak, Andrej
CHEMICAL AND SYNTHETIC BIOLOGY APPROACHES TO UNDERSTAND CELLULAR FUNCTIONS - PT A, 2019, 621 : 329 - 346
[9] A high-throughput digital imaging screen for the discovery and directed evolution of oxygenases
Joo, H
Arisawa, A
Lin, ZL
Arnold, FH
CHEMISTRY & BIOLOGY, 1999, 6 (10): : 699 - 706
[10] Target-directed discovery and production of pharmaceuticals in transgenic mutant plant cells
Brown, D. P.
Rogers, D. T.
Gunjan, S. K.
Gerhardt, G. A.
Littleton, J. M.
JOURNAL OF BIOTECHNOLOGY, 2016, 238 : 9 - 14

← 1 2 3 4 5 →